Article Versions Notes

Rebuzzi SE, Banna GL, Murianni V, Damassi A, Giunta EF, Fraggetta F, De Giorgi U, Cathomas R, Rescigno P, Brunelli M, et al. Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence. Cancers. 2021; 13(21):5517. https://doi.org/10.3390/cancers13215517

Rebuzzi, Sara Elena, Giuseppe Luigi Banna, Veronica Murianni, Alessandra Damassi, Emilio Francesco Giunta, Filippo Fraggetta, Ugo De Giorgi, Richard Cathomas, Pasquale Rescigno, Matteo Brunelli, and et al. 2021. "Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence" Cancers 13, no. 21: 5517. https://doi.org/10.3390/cancers13215517

Rebuzzi, S. E., Banna, G. L., Murianni, V., Damassi, A., Giunta, E. F., Fraggetta, F., De Giorgi, U., Cathomas, R., Rescigno, P., Brunelli, M., & Fornarini, G. (2021). Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence. Cancers, 13(21), 5517. https://doi.org/10.3390/cancers13215517